Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.
Li M, Sagastume EA, Lee D, McAlister D, DeGraffenreid AJ, Olewine KR, Graves S, Copping R, Mirzadeh S, Zimmerman BE, Larsen RH, Johnson FL, Schultz MK. Li M, et al. Among authors: sagastume ea. Curr Med Chem. 2020;27(41):7003-7031. doi: 10.2174/0929867327999200727190423. Curr Med Chem. 2020. PMID: 32720598 Free PMC article. Review.
Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.
Lee D, Li M, Liu D, Baumhover NJ, Sagastume EA, Marks BM, Rastogi P, Pigge FC, Menda Y, Johnson FL, Schultz MK. Lee D, et al. Among authors: sagastume ea. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1147-1162. doi: 10.1007/s00259-023-06494-9. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37955792 Free PMC article.
Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy.
Li M, Robles-Planells C, Liu D, Graves SA, Vasquez-Martinez G, Mayoral-Andrade G, Lee D, Rastogi P, Marks BM, Sagastume EA, Weiss RM, Linn-Peirano SC, Johnson FL, Schultz MK, Zepeda-Orozco D. Li M, et al. Among authors: sagastume ea. bioRxiv [Preprint]. 2023 Sep 29:2023.09.27.559789. doi: 10.1101/2023.09.27.559789. bioRxiv. 2023. PMID: 37808634 Free PMC article. Updated. Preprint.
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy.
Li M, Robles-Planells C, Liu D, Graves SA, Vasquez-Martinez G, Mayoral-Andrade G, Lee D, Rastogi P, Marks BM, Sagastume EA, Weiss RM, Linn-Peirano SC, Johnson FL, Schultz MK, Zepeda-Orozco D. Li M, et al. Among authors: sagastume ea. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1395-1408. doi: 10.1007/s00259-023-06559-9. Epub 2023 Dec 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 38095674 Free PMC article.
Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.
Li M, Liu D, Lee D, Kapoor S, Gibson-Corley KN, Quinn TP, Sagastume EA, Mott SL, Walsh SA, Acevedo MR, Johnson FL, Schultz MK. Li M, et al. Among authors: sagastume ea. Mol Pharm. 2019 Sep 3;16(9):3904-3915. doi: 10.1021/acs.molpharmaceut.9b00512. Epub 2019 Jul 31. Mol Pharm. 2019. PMID: 31318566 Free PMC article.